Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters










Publication year range
1.
Mol Cancer ; 23(1): 124, 2024 Jun 07.
Article in English | MEDLINE | ID: mdl-38849840

ABSTRACT

BACKGROUND: Intestinal metaplasia (IM) is classified into complete intestinal metaplasia (CIM) and incomplete intestinal metaplasia (IIM). Patients diagnosed with IIM face an elevated susceptibility to the development of gastric cancer, underscoring the critical need for early screening measures. In addition to the complexities associated with diagnosis, the exact mechanisms driving the progression of gastric cancer in IIM patients remain poorly understood. OLFM4 is overexpressed in several types of tumors, including colorectal, gastric, pancreatic, and ovarian cancers, and its expression has been associated with tumor progression. METHODS: In this study, we used pathological sections from two clinical centers, biopsies of IM tissues, precancerous lesions of gastric cancer (PLGC) cell models, animal models, and organoids to explore the role of OLFM4 in IIM. RESULTS: Our results show that OLFM4 expression is highly increased in IIM, with superior diagnostic accuracy of IIM when compared to CDX2 and MUC2. OLFM4, along with MYH9, was overexpressed in IM organoids and PLGC animal models. Furthermore, OLFM4, in combination with Myosin heavy chain 9 (MYH9), accelerated the ubiquitination of GSK3ß and resulted in increased ß-catenin levels through the Wnt signaling pathway, promoting the proliferation and invasion abilities of PLGC cells. CONCLUSIONS: OLFM4 represents a novel biomarker for IIM and could be utilized as an important auxiliary means to delimit the key population for early gastric cancer screening. Finally, our study identifies cell signaling pathways involved in the progression of IM.


Subject(s)
Disease Progression , Glycogen Synthase Kinase 3 beta , Metaplasia , Myosin Heavy Chains , beta Catenin , Humans , Metaplasia/metabolism , Metaplasia/pathology , Metaplasia/genetics , Glycogen Synthase Kinase 3 beta/metabolism , Animals , beta Catenin/metabolism , beta Catenin/genetics , Mice , Myosin Heavy Chains/metabolism , Myosin Heavy Chains/genetics , Stomach Neoplasms/pathology , Stomach Neoplasms/metabolism , Stomach Neoplasms/genetics , Female , Wnt Signaling Pathway , Cell Proliferation , Cell Line, Tumor , Gene Expression Regulation, Neoplastic , Disease Models, Animal , Male , Organoids/metabolism , Organoids/pathology
2.
Gastrointest Endosc ; 99(6): 1075, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38762303
3.
Nutrients ; 15(24)2023 Dec 13.
Article in English | MEDLINE | ID: mdl-38140350

ABSTRACT

BACKGROUND AND AIMS: The efficacy and underlying mechanisms of exclusive enteral nutrition (EEN) in adult patients with Crohn's disease (CD) remain controversial. This study aimed to evaluate the role of EEN in adult patients with CD and to explore the mechanisms from the perspective of immunoregulation. METHODS: This is a prospective, open-label pilot study. Active patients with CD were enrolled and prescribed an amino-acid-rich elemental diet for 12 weeks. Dynamic changes in immune cells, including neutrophils, monocytes, T cells and B cells, were detected by flow cytometry. Plasma cytokines were evaluated by ELISA. RESULTS: Twenty adult patients with CD were enrolled. Among them, 1 discontinued treatment due to poor compliance, and 19 patients were included for final analysis. Clinical remission was achieved in 47.37% (9/19), 63.16% (12/19), and 73.68% (14/19) patients at weeks 4, 8, and 12, respectively. Endoscopic remission and transmural healing were achieved in 52.63% (10/19) and 15.79% (3/19) patients at week 12. Notably, there was no significant difference in clinical remission between week 4 and week 8 (p = 0.33) or week 12 (p = 0.09). Furthermore, we observed a rapid reconstitution of immunologic homeostasis as early as week 4. At week 4, both the frequency and activation of neutrophils and monocytes were decreased after EEN therapy. Significant decreases in Th17 cells and naïve B cells, increases in memory B cells, and regulatory B cells were also detected. These changes remained stable at weeks 8 and 12. CONCLUSIONS: EEN with an amino-acid-rich elemental diet orchestrated immunological balances and induces clinical remission in adult CD patients as early as week 4, suggesting a 4-week EEN therapy may be feasible and practicable in clinical practice.


Subject(s)
Crohn Disease , Adult , Humans , Crohn Disease/therapy , Enteral Nutrition , Prospective Studies , Pilot Projects , Remission Induction
4.
Adv Healthc Mater ; 12(27): e2301243, 2023 10.
Article in English | MEDLINE | ID: mdl-37463303

ABSTRACT

The mortality rate of sepsis remains high despite improvements in the diagnosis and treatment of sepsis using symptomatic and supportive therapies, such as anti-infection therapy and fluid resuscitation. Nucleic acid-based drugs have therapeutic potential, although their poor stability and low delivery efficiency have hindered their widespread use. Herein, it is confirmed that miR-223 can polarize proinflammation M1 macrophages to anti-inflammation M2 macrophages. A pH-sensitive nano-drug delivery system comprising ß-cyclodextrin-poly(2-(diisopropylamino)ethyl methacrylate)/distearoyl phosphoethanolamine-polyethylene glycol (ß-CD-PDPA/DSPE-PEG) is synthesized and developed to target M1 macrophages and miR-223 is encapsulated into nanoparticles (NPs) for sepsis treatment. NPs/miR-223 demonstrated in vitro pH responsiveness with favorable biosafety, stability, and high delivery efficiency. In vivo studies demonstrate that NPs/miR-223 are preferentially accumulated and retained in the inflammation site, thereby reducing inflammation and improving the survival rate of mice with sepsis while exhibiting ideal biosafety. Mechanically, NPs/miR-223 regulates macrophage polarization by targeting Pknox1 and inhibiting the activation of the NF-κB signaling pathway, thereby achieving an anti-inflammatory effect. Collectively, it is demonstrated that the miRNA delivery vector described here provides a new approach for sepsis treatment and accelerates the advancement of nucleic acid drug therapy.


Subject(s)
Cyclodextrins , MicroRNAs , Sepsis , Animals , Mice , MicroRNAs/genetics , Macrophages/metabolism , Inflammation/metabolism , Sepsis/drug therapy , Sepsis/metabolism , Hydrogen-Ion Concentration , Homeodomain Proteins/metabolism
5.
Entropy (Basel) ; 25(4)2023 Apr 18.
Article in English | MEDLINE | ID: mdl-37190467

ABSTRACT

This paper investigates lift, the likelihood ratio between the posterior and prior belief about sensitive features in a dataset. Maximum and minimum lifts over sensitive features quantify the adversary's knowledge gain and should be bounded to protect privacy. We demonstrate that max- and min-lifts have a distinct range of values and probability of appearance in the dataset, referred to as lift asymmetry. We propose asymmetric local information privacy (ALIP) as a compatible privacy notion with lift asymmetry, where different bounds can be applied to min- and max-lifts. We use ALIP in the watchdog and optimal random response (ORR) mechanisms, the main methods to achieve lift-based privacy. It is shown that ALIP enhances utility in these methods compared to existing local information privacy, which ensures the same (symmetric) bounds on both max- and min-lifts. We propose subset merging for the watchdog mechanism to improve data utility and subset random response for the ORR to reduce complexity. We then investigate the related lift-based measures, including ℓ1-norm, χ2-privacy criterion, and α-lift. We reveal that they can only restrict max-lift, resulting in significant min-lift leakage. To overcome this problem, we propose corresponding lift-inverse measures to restrict the min-lift. We apply these lift-based and lift-inverse measures in the watchdog mechanism. We show that they can be considered as relaxations of ALIP, where a higher utility can be achieved by bounding only average max- and min-lifts.

6.
ACS Appl Mater Interfaces ; 15(17): 20697-20711, 2023 May 03.
Article in English | MEDLINE | ID: mdl-37083309

ABSTRACT

Conventional chemotherapy usually fails to achieve its intended effect because of the poor water solubility, poor tumor selectivity, and low tumor accumulation of chemotherapy drugs. The systemic toxicity of chemotherapy agents is also a problem that cannot be ignored. It is expected that smart nano-drug delivery systems that are able to respond to tumor microenvironments will provide better therapeutic outcomes with decreased side effects of chemotherapeutics. Nano-drug delivery systems capable of breaking the redox balance can also increase the sensitivity of tumor cells to chemotherapeutics. In this study, using polymer-containing disulfide bonds, ester bonds, and d-α-tocopherol polyethylene glycol succinate (TPGS), which can amplify reactive oxygen species (ROS) in tumor cells, we have successfully prepared a smart glutathione (GSH) and esterase dual-responsive nano-drug delivery system (DTX@PAMBE-SS-TPGS NPs) with the ability to deplete GSH as well as amplify ROS and effectively release an encapsulated chemotherapy drug (DTX) in tumor cells. The potential of DTX@PAMBE-SS-TPGS NPs for enhanced antitumor effects was thoroughly evaluated using in vitro as well as in vivo experiments. Our research offers a promising strategy for maximizing the efficacy of tumor therapy.


Subject(s)
Antineoplastic Agents , Nanoparticles , Nanoparticle Drug Delivery System , Reactive Oxygen Species , Nanoparticles/chemistry , Antineoplastic Agents/chemistry , Glutathione/metabolism , Oxidation-Reduction , Cell Line, Tumor
7.
J Colloid Interface Sci ; 628(Pt B): 864-876, 2022 Dec 15.
Article in English | MEDLINE | ID: mdl-36029600

ABSTRACT

Drug delivery based on abnormal features of the tumor microenvironment (TME) has attracted considerable interest worldwide. In this study, we proposed an applicable strategy to increase the reactive oxygen species (ROS) and inhibit glutathione (GSH), in an effort to amplify oxidative damage in prostate cancer cells. Specifically, we developed dual-responsive supramolecular self-assembled nanoparticles (NPs) based on polymerized methacrylic acid (MA) and polymerized poly(ethylene glycol) dimethyl acrylate-modified ß-cyclodextrin (CD) with ferrocene (Fc)-connected (S) (+)-camptothecin (CPT) (designated as MA-CD/Fc-CPT NPs). The as-prepared negatively charged supramolecular NPs can be taken up by tumor cells successfully owing to their reversible negative-to-positive charge transition capacity at acidic pH. The supramolecular NPs increased ROS generation and decreased GSH to amplify oxidative stress and improve the therapeutic effect of chemotherapy. As expected, MA-CD/Fc-CPT NPs displayed good drug delivery capabilities to tumor cells or tissues. MA-CD/Fc-CPT NPs also inhibited cancer cell proliferation in both the cells and tissues. This result was partially due to increased ROS generation and decreased GSH, which contributed to more pronounced oxidative stress. The as-prepared supramolecular NPs displayed great biosafety to normal tissues. According to our results, negatively charged supramolecular MA-CD/Fc-CPT NPs are well-suited for drug delivery and improved cancer treatment in TMEs.


Subject(s)
Cyclodextrins , Nanoparticles , beta-Cyclodextrins , Male , Humans , Reactive Oxygen Species , Metallocenes , Nanoparticles/chemistry , Camptothecin/chemistry , Oxidation-Reduction , Methacrylates , Glutathione , Polyethylene Glycols , Cell Line, Tumor
8.
Transpl Immunol ; 74: 101660, 2022 10.
Article in English | MEDLINE | ID: mdl-35787932

ABSTRACT

BACKGROUND: Sepsis in patients is a great threat to human health due to its high incidence rate, its rapid and unpredictable progression, as well as it is difficult to treat, and it has poor prognosis. Ferroptosis is a newly discovered type of cell death characterized by the iron-dependent peroxide aggregation. Furthermore, ferroptosis is different from other forms of cell death, namely apoptosis, necrosis, pyroptosis and autophagy. Our study investigated the role of ferroptosis-related genes in sepsis. METHODS: The GSE65682 dataset from the Gene Expression Omnibus (GEO) database was used to screen ferroptosis-related genes associated with sepsis, and the GSE134347 dataset for the external validation of selected hub genes. The univariate Cox regression analysis, Kaplan-Meier (K-M) survival analysis and weighted gene co-expression network analysis (WGCNA) were used to identify hub genes. Evaluation of the immune cell infiltration in sepsis was used to explain the immune heterogeneity among the cell subtypes. Gene set variation analysis (GSVA) and transcriptional regulatory analysis of selected hub genes further elucidated the probable mechanism of ferroptosis-related genes associated with prognosis in sepsis. Finally, we constructed a competing endogenous RNA (ceRNA) network model. RESULTS: A total of 479 RNA-seq data points were used for analysis, including 365 samples from patients who survived sepsis and 114 samples from patients who succumbed to sepsis from the available GSE65682 dataset. Consequently, the univariate Cox regression analysis and consensus clustering analysis divide all 479 sepsis samples into two clusters of "survivals" vs. "non-survivals". Following complex analysis were identified as the most important ferroptosis-related genes. Indeed, the WGCNA and K-M analyses associated the expression patterns of NEDD4L and SIAH2 hub genes as the best prognosis for the survival of sepsis (p < 0.05). The expression trend was also consistent with the survival trend of the NEDD4L and SIAH2 hub genes by the external validation of GSE134347 (p < 0.05). Immune cell infiltration analysis indicated that the types and numbers of different immune cells vary among different subtypes and NEDD4L and SIAH2 hub genes. For example, NEDD4L and SIAH2 gene expression had a positive correlation with M0 macrophages and a negative correlation with neutrophils (p > 0.05). Finally, analysis of two hub genes and transcription factors (TFs) showed that 71 TFs were predicted to be related to NEDD4L while 64 TFs to SIAH2 by the Cistrome DB online database. CONCLUSION: We suggest that NEDD4L and SIAH2 hub genes are involved in the ferroptosis-associated sepsis. The pattern of NEDD4L and SIAH2 expression in patients undergoing sepsis may have prognostic potential for the severity of sepsis and eventually for patients' survival.


Subject(s)
Ferroptosis , Sepsis , Apoptosis , Ferroptosis/genetics , Gene Expression Profiling , Humans , Prognosis , Sepsis/genetics
9.
Aliment Pharmacol Ther ; 55(7): 764-777, 2022 04.
Article in English | MEDLINE | ID: mdl-35141914

ABSTRACT

BACKGROUND: Ustekinumab is effective in treating Crohn's disease (CD) and ulcerative colitis (UC). However, the loss of response (LOR) to ustekinumab and the efficacy of dose escalation have not been systematically explored. METHODS: Databases were searched for eligible studies from inception through July 2021. Summary estimates were pooled, and subgroup analyses were performed to explore heterogeneity. RESULTS: We included 14 studies (CD: 13; UC: 1). In CD patients, the annual risk of LOR to ustekinumab and dose escalation among primary responders was 21% (95% confidence interval [CI] 12-31%, 1530 person-years, n = 9) per person-year and 25% (95% CI 12-32%, 657 person-years, n = 5) per person-year respectively. Clinical response was regained in 58% (95% CI 49-67%, 279 patients, n = 8) of secondary non-responders after dose escalation (interval reduction or intravenous reinduction). In UC patients, no studies provided data on LOR, but only one study showed that 35% (100/284) of patients underwent dose escalation (or sham dose adjustment), leading to an annual risk of dose escalation of 18% per person-year. After dose escalation, 58% (14/24) of the patients regained symptomatic remission. CONCLUSIONS: Primary responders with CD experienced LOR to ustekinumab at a risk of 21% per person-year and required dose escalation at a risk of 25% per person-year. Fifty-eight per cent of secondary non-responders with CD may benefit from dose escalation. LOR has not been well characterized in patients with UC.


Subject(s)
Inflammatory Bowel Diseases , Ustekinumab , Colitis, Ulcerative/drug therapy , Crohn Disease/drug therapy , Humans , Inflammatory Bowel Diseases/drug therapy , Ustekinumab/administration & dosage
10.
Entropy (Basel) ; 24(1)2022 Jan 11.
Article in English | MEDLINE | ID: mdl-35052135

ABSTRACT

This paper studies how to attain fairness in communication for omniscience that models the multi-terminal compress sensing problem and the coded cooperative data exchange problem where a set of users exchange their observations of a discrete multiple random source to attain omniscience-the state that all users recover the entire source. The optimal rate region containing all source coding rate vectors that achieve omniscience with the minimum sum rate is shown to coincide with the core (the solution set) of a coalitional game. Two game-theoretic fairness solutions are studied: the Shapley value and the egalitarian solution. It is shown that the Shapley value assigns each user the source coding rate measured by their remaining information of the multiple source given the common randomness that is shared by all users, while the egalitarian solution simply distributes the rates as evenly as possible in the core. To avoid the exponentially growing complexity of obtaining the Shapley value, a polynomial-time approximation method is proposed which utilizes the fact that the Shapley value is the mean value over all extreme points in the core. In addition, a steepest descent algorithm is proposed that converges in polynomial time on the fractional egalitarian solution in the core, which can be implemented by network coding schemes. Finally, it is shown that the game can be decomposed into subgames so that both the Shapley value and the egalitarian solution can be obtained within each subgame in a distributed manner with reduced complexity.

11.
Nutr Clin Pract ; 37(2): 366-376, 2022 Apr.
Article in English | MEDLINE | ID: mdl-34245474

ABSTRACT

BACKGROUND: Conventional treatment for Crohn disease (CD) in pregnancy includes mesalamine, thiopurine, and anti-tumor necrosis factor (TNF)-α agents. However, women may abstain because of complications, nonresponse, or potential adverse outcomes. Peptide-based formula therapy, through oral or nasogastric feeding without other food intake, is an effective and safe therapy for active CD. Herein, We confirmed the effectiveness and safety of peptide-based formula therapy for active CD in pregnant women or those preparing for pregnancy. METHOD: Outcomes of peptide-based formula therapy to induce CD remission during pregnancy preparation and the conception period were evaluated retrospectively among 14 women. Efficacy was evaluated as the change in serum indices and inflammatory markers after 12-week treatment. Pregnancy outcomes were compared between 14 women treated with nutrition therapy and eight women using conventional CD drugs. RESULTS: After 12 weeks, 85.7% (12 of 14) of patients treated with peptide-based formula achieved remission with a significant decrease in the CD activity index (P < .001) and high-sensitivity C-reactive protein level (P = .004). There were no effects of peptide-based formula therapy on pregnancy outcomes compared with conventional CD treatment (P > .05). Among the 12 patients who achieved CD remission with exclusive peptide-based formula therapy, 10 selected to continue total or partial peptide-based formula treatment to maintain CD remission throughout pregnancy. CONCLUSION: Peptide-based formula therapy, without other food intake, may provide a safe and effective alternative to conventional CD drugs to induce disease remission among women during conception and pregnancy.


Subject(s)
Crohn Disease , Crohn Disease/drug therapy , Enteral Nutrition , Female , Humans , Peptides/therapeutic use , Pregnancy , Remission Induction , Retrospective Studies , Treatment Outcome
12.
J Immunother Cancer ; 10(12)2022 12.
Article in English | MEDLINE | ID: mdl-36600557

ABSTRACT

BACKGROUND: As an integral part of the tumor microenvironment (TME), tumor-associated neutrophils play a crucial role in tumor development. The objective of this study was to investigate the plasticity of tumor-associated N1 and N2 neutrophils in the TME of pancreatic ductal adenocarcinoma (PDAC), along with its impact on survival and association with immune infiltrations. METHODS: The primary and validation cohorts including 90 radical resection patients from September 2012 to May 2016 and 29 radical resection patients from September 2018 to October 2019, respectively, with complete survival data, were enrolled. Immunofluorescence staining was used to identify tumor-associated N1 and N2 neutrophils, and the N1/N2 ratio was used to evaluate N1 and N2 plasticity. Thereafter, the association between tumor-associated N1/N2 neutrophil plasticity, clinical features, and immune infiltrations was investigated. RESULTS: There was a significant increase in tumor-associated N2 neutrophils compared with tumor-associated N1 neutrophils. Low N1/N2 ratios were associated with the poorer differentiation of tumors, easier lymph node metastases, and a higher TNM stage. The median overall survival (OS) and recurrence-free survival (RFS) of the high tumor-associated N1 neutrophil group were significantly longer than those of the low group, while the tumor-associated N2 neutrophils played an opposite role. The multivariable analysis revealed that a high N1/N2 ratio was a significant prognostic indicator for OS and RFS. In addition, tumor-associated N1/N2 neutrophils showed an opposite correlation with tumor-infiltrating CD8+ T cells and Tregs. CONCLUSION: The plasticity of tumor-associated N1/N2 neutrophils was identified as a crucial prognostic indicator that might reflect the TME and immune escape in patients with PDAC. On further investigation and validation, our findings may be used to further stratify patients with varying prognoses to optimize treatment.


Subject(s)
Carcinoma, Pancreatic Ductal , Pancreatic Neoplasms , Humans , Prognosis , Neutrophils/pathology , CD8-Positive T-Lymphocytes/pathology , Pancreatic Neoplasms/pathology , Carcinoma, Pancreatic Ductal/surgery , Pancreas/pathology , Tumor Microenvironment , Pancreatic Neoplasms
14.
Poult Sci ; 98(10): 4401-4407, 2019 Oct 01.
Article in English | MEDLINE | ID: mdl-31041437

ABSTRACT

Preserved egg, a traditional Chinese egg product, is regarded as an anti-inflammatory food in traditional Chinese medicine. This study was aimed to examine anti-inflammatory effect of the simulated gastrointestinal digestive products of whole preserved egg (DWPE), preserved egg white (DPEW), and preserved egg yolk (DPEY) on lipopolysaccharide (LPS)-stimulated RAW264.7 cells. The results demonstrated that DWPE, DPEW, or DPEY inhibited the LPS-induced secretion of Nitric oxide (NO), without marked cytotoxicity. The DWPE, DPEW, and DPEY significantly suppressed the secretion of pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-α and interleukin (IL)-6. Particularly, the inhibition rate of DPEW on NO, IL-6, and TNF-α could reach 25 to 27%, 31 to 42%, and 26 to 38%, respectively (P < 0.05). Furthermore, the DPEW and DPEY downregulated the gene expression of Cyclooxygenase-2 and inducible nitric oxide synthase in a dose-dependent manner. Taken together, this study indicated that DWPE, DPEW, and DPEY, especially DPEW, might serve as functional food for anti-inflammatory therapy.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Egg White/chemistry , Egg Yolk/chemistry , Inflammation/drug therapy , Ovum/drug effects , Animals , Anti-Inflammatory Agents/administration & dosage , Eggs/analysis , Medicine, Chinese Traditional , Mice , RAW 264.7 Cells
15.
J Surg Res ; 228: 93-99, 2018 08.
Article in English | MEDLINE | ID: mdl-29907236

ABSTRACT

BACKGROUND: Although peritoneal lavage with povidone-iodine (PVPI) is frequently performed after surgery on the gastrointestinal tract, the effects of PVPI on the intestinal epithelial barrier are unknown. The purpose of this study was to investigate the effects of abdominal irrigation with PVPI on the intestinal epithelial barrier in a colorectal cancer (CRC)-induced rat model. MATERIALS AND METHODS: The CRC model was induced in rats with azoxymethane and dextran sodium sulfate. Next, a total of 24 male CRC-induced rats were randomly divided into three groups (n = 8): (1) a sham-operated group, (2) an NS group (peritoneal lavage 0.9% NaCl), and (3) a PVPI group (peritoneal lavage with 0.45%-0.55% PVPI). The mean arterial pressure was continuously monitored throughout the experiment. The levels of plasma endotoxin and D-lactate, blood gases, and protein concentration were measured. The ultrastructural changes of the epithelial tight junctions were observed by transmission electron microscopy. RESULTS: The mean arterial pressure after peritoneal lavage was lower in the PVPI group than that in the NS group. The protein concentration and levels of endotoxin and D-lactate were higher in the PVPI group than they were in the PVPI group. In addition, PVPI treatment resulted in a markedly severe metabolic acidosis and intestinal mucosal injury compared with NS rats. CONCLUSIONS: Peritoneal lavage with PVPI dramatically compromises the integrity of the intestinal mucosa barrier and causes endotoxin shock in CRC rats. It is unsafe for clinical applications to include peritoneal lavage with PVPI in colorectal operations.


Subject(s)
Anti-Infective Agents, Local/adverse effects , Colorectal Neoplasms/surgery , Peritoneal Lavage/adverse effects , Povidone-Iodine/adverse effects , Shock, Septic/chemically induced , Acidosis/chemically induced , Acidosis/diagnosis , Animals , Anti-Infective Agents, Local/administration & dosage , Anti-Infective Agents, Local/pharmacokinetics , Azoxymethane/toxicity , Bacterial Translocation/drug effects , Colorectal Neoplasms/chemically induced , Dextran Sulfate/toxicity , Endotoxins/blood , Endotoxins/metabolism , Gastrointestinal Microbiome/drug effects , Gastrointestinal Microbiome/physiology , Humans , Intestinal Mucosa/cytology , Intestinal Mucosa/drug effects , Intestinal Mucosa/metabolism , Male , Microscopy, Electron, Transmission , Neoplasms, Experimental/chemically induced , Neoplasms, Experimental/surgery , Peritoneal Absorption , Peritoneal Lavage/methods , Permeability/drug effects , Povidone-Iodine/administration & dosage , Povidone-Iodine/pharmacokinetics , Rats , Rats, Sprague-Dawley , Shock, Septic/blood , Shock, Septic/diagnosis , Tight Junctions/drug effects , Tight Junctions/ultrastructure
16.
Dalton Trans ; 45(12): 5092-100, 2016 Mar 28.
Article in English | MEDLINE | ID: mdl-26883749

ABSTRACT

Polymorphic compounds {[Cu(dcbb)2(H2O)2]·10H2O}n (2, 1D chain), [Cu(dcbb)2]n (3, 2D layer) and their co-crystal {[Cu(dcbb)2(H2O)][Cu(dcbb)2]2}n (4) have been prepared from the coordination reaction of a 2D polymer [Na(dcbb)(H2O)]n (1, H2dcbbBr = 1-(3,5-dicarboxybenzyl)-4,4'-bipyridinium bromide) with Cu(NO3)2·3H2O at different temperatures in water. Compounds 2-4 have an identical metal-to-ligand stoichiometric ratio of 1 : 2, but absolutely differ in structure. Compound 3 features a 2D layer structure with aromatic rings, positively charged pyridinium and free carboxylates on its surface, promoting electrostatic, π-stacking and/or hydrogen-bonding interactions with the carboxyfluorescein (FAM) labeled probe single-stranded DNA (probe ss-DNA, delineates as P-DNA). The resultant P-DNA@3 system facilitated fluorescence quenching of FAM via a photoinduced electron transfer process. The P-DNA@3 system functions as an efficient fluorescent sensor selective for HIV double-stranded DNA (HIV ds-DNA) due to the formation of a rigid triplex structure with the recovery of FAM fluorescence. The system reported herein also distinguishes complementary HIV ds-DNA from mismatched target DNA sequences with the detection limit of 1.42 nM.


Subject(s)
DNA/chemistry , HIV/genetics , Coordination Complexes/chemical synthesis , Coordination Complexes/chemistry , Copper/chemistry , Crystallography, X-Ray , DNA/metabolism , Fluoresceins/chemistry , Hydrogen Bonding , Molecular Conformation , Polymers/chemistry , Spectrometry, Fluorescence
17.
Inorg Chem ; 53(14): 7446-54, 2014 Jul 21.
Article in English | MEDLINE | ID: mdl-24967909

ABSTRACT

A variety of network structures have been prepared by transmetalation of a polymer {Na3[Na9(Cbdcp)6(H2O)18]}n (1) (Cbdcp = N-(4-carboxybenzyl)-(3,5-dicarboxyl)pyridinium) containing dodecahedral Na9 aggregate secondary building units with Cu(II) by modulating the temperature, solvent, and pH. These complexes include a large, zwitterionic hexa-cuprometallocycle [Cu6(Cbdcp)6(H2O)18] (2) formed in H2O at room temperature, two three-dimensional polymers [Cu3(Cbdcp)2(OH)2(H2O)2]n (3) and {[Cu3(Cbdcp)2(OH)2]·2H2O}n (4) isolated from H2O and DMF/H2O at 135 °C, and a mononuclear complex [Cu(HCbdcp)2(H2O)3]·H2O (5) from H2O at 100 °C and pH = 6. All the complexes are robust and water stable. The crystal framework of macrocycle 2 is stable up to 100 °C under vacuum and selectively adsorbs CO2.


Subject(s)
Copper/chemistry , Polymers/chemistry , Sodium/chemistry , Crystallography, X-Ray , Models, Molecular , Water/chemistry
18.
Angew Chem Int Ed Engl ; 53(18): 4628-32, 2014 Apr 25.
Article in English | MEDLINE | ID: mdl-24692130

ABSTRACT

A 2D coordination polymer prepared with bulky diethylformamide solvates exhibits channels which allow dipyridyl bridging ligands to diffuse into the crystal lattice. The absorbed dipyridyls thread through the pores of one layer and substitute the surface diethylformamide molecules on the neighboring layers to stitch alternate layers to form flexible interpenetrated metal-orgaic frameworks. The threading process also results in exchange of the bulky diethylformamide solvates for aqua to minimize congestion and, more strikingly, forces the slippage of two-dimensional layers, while still maintaining crystallinity.


Subject(s)
Cadmium/chemistry , Organometallic Compounds/chemistry , Polymers/chemistry , 2,2'-Dipyridyl/chemistry , Carbon Dioxide/chemistry , Crystallography, X-Ray , Dimethylformamide/analogs & derivatives , Dimethylformamide/chemistry , Models, Molecular , Nitrogen/chemistry
19.
Neuropharmacology ; 59(6): 518-26, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20659488

ABSTRACT

Risky decision making is a complex process that involves weighing the probabilities of alternative options that can be desirable, undesirable, or neutral. Individuals vary greatly in how they make decisions either under ambiguity and/or under risk. Such individual differences may have genetic bases. Based on previous studies on the genetic basis of decision making, two decision making tasks [i.e., the Iowa Gambling Task (IGT) and Loss Aversion Task (LAT)] were used to test the effect of 5-HTTLPR polymorphism on decision making under ambiguity and under risk in a large Han Chinese sample (572 college students, 312 females). Basic intelligence and memory tests were also included to control for the influence of basic cognitive abilities on decision making. We found that 5-HTTLPR polymorphism significantly influenced performance in both IGT and LAT. After controlling for intelligence and memory abilities, subjects homozygous for s allele had lower IGT scores than l carriers in the first 40 trials of the IGT task. They also exhibited higher loss aversion than l carriers in the LAT task. Moreover, the effects of 5-HTTLPR were stronger for males than for females. These results extend the literature on the important role of emotion in decision making under ambiguity and risk, and shed additional lights on how decision making is influenced by culture as well as sex differences. Combining our results with existing literature, we propose that these effects might be mediated by a neural circuitry that comprises the amygdala, ventromedial prefrontal cortex, and insular cortex. Understanding the genetic factors affecting decision making in healthy subjects may allow us to better identify at-risk individuals, and better target the development of new potential treatments for specific disorders such as schizophrenia, addiction, and depression.


Subject(s)
Decision Making/physiology , Polymorphism, Genetic , Serotonin Plasma Membrane Transport Proteins/genetics , Alleles , Asian People/genetics , Emotions/physiology , Female , Genotype , Humans , Male , Memory/physiology , Neuropsychological Tests , Sex Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...